世界の陽電子放射形コンピューター断層撮影法(PET)装置市場:医療機器パイプライン分析2016

◆英語タイトル:Positron Emission Tomography (PET) Systems - Medical Devices Pipeline Assessment, 2016
◆商品コード:GDME0199EPD
◆発行会社(調査会社):GlobalData
◆発行日:2016年6月1日
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥277,500見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥555,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥832,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、陽電子放射形コンピューター断層撮影法(PET)装置のグローバル製品パイプライン動向について調査・分析し、以下の構成でお届けいたします。
・陽電子放射形コンピューター断層撮影法(PET)装置の概要
・陽電子放射形コンピューター断層撮影法(PET)装置の開発動向:開発段階別分析
・陽電子放射形コンピューター断層撮影法(PET)装置の開発動向:セグメント別分析
・陽電子放射形コンピューター断層撮影法(PET)装置の開発動向:領域別分析
・陽電子放射形コンピューター断層撮影法(PET)装置の開発動向:規制Path別分析
・陽電子放射形コンピューター断層撮影法(PET)装置の開発動向:承認日(推定)別分析
・企業別陽電子放射形コンピューター断層撮影法(PET)装置の開発動向(パイプライン製品、進行中の治験)
・陽電子放射形コンピューター断層撮影法(PET)装置の最近動向
【レポートの概要】

Positron Emission Tomography (PET) Systems – Medical Devices Pipeline Assessment, 2016

Summary

GlobalData’s Medical Devices sector report, “Positron Emission Tomography (PET) Systems – Medical Devices Pipeline Assessment, 2016″ provides an overview of Positron Emission Tomography (PET) Systems currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Positron Emission Tomography (PET) Systems pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Positron Emission Tomography (PET) Systems under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Positron Emission Tomography (PET) Systems and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Positron Emission Tomography (PET) Systems under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 Positron Emission Tomography (PET) Systems Overview 6
3 Products under Development 7
3.1 Positron Emission Tomography (PET) Systems – Pipeline Products by Stage of Development 7
3.2 Positron Emission Tomography (PET) Systems – Pipeline Products by Territory 8
3.3 Positron Emission Tomography (PET) Systems – Pipeline Products by Regulatory Path 9
3.4 Positron Emission Tomography (PET) Systems – Pipeline Products by Estimated Approval Date 10
3.5 Positron Emission Tomography (PET) Systems – Ongoing Clinical Trials 11
4 Positron Emission Tomography (PET) Systems – Pipeline Products under Development by Companies 12
4.1 Positron Emission Tomography (PET) Systems Companies – Pipeline Products by Stage of Development 12
4.2 Positron Emission Tomography (PET) Systems – Pipeline Products by Stage of Development 13
5 Positron Emission Tomography (PET) Systems Companies and Product Overview 14
5.1 Brain Biosciences Inc Company Overview 14
5.1.1 Brain Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 14
5.2 GE Healthcare Limited Company Overview 15
5.2.1 GE Healthcare Limited Pipeline Products & Ongoing Clinical Trials Overview 15
5.3 Jagiellonian University Company Overview 16
5.3.1 Jagiellonian University Pipeline Products & Ongoing Clinical Trials Overview 16
5.4 Philips Healthcare Company Overview 17
5.4.1 Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview 17
5.5 Ray Vision Intl Corp. Company Overview 21
5.5.1 Ray Vision Intl Corp. Pipeline Products & Ongoing Clinical Trials Overview 21
5.6 Stanford University Company Overview 22
5.6.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 22
5.7 SynchroPET Company Overview 27
5.7.1 SynchroPET Pipeline Products & Ongoing Clinical Trials Overview 27
5.8 The University of British Columbia Company Overview 29
5.8.1 The University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview 29
5.9 Zecotek Photonics Inc. Company Overview 30
5.9.1 Zecotek Photonics Inc. Pipeline Products & Ongoing Clinical Trials Overview 30
6 Positron Emission Tomography (PET) Systems- Recent Developments 32
6.1 May 27, 2016: FDA approves new diagnostic imaging agent to detect recurrent prostate cancer 32
6.2 May 26, 2016: Advanced Accelerator Applications to Acquire Two Production Sites in Germany 32
6.3 May 26, 2016: Advanced Accelerator Applications Appoints Francois Nader, M.D., to Board of Directors 33
6.4 May 25, 2016: FluoroPharma Medical Announces Acceptance of CardioPET Data for Presentation at the 21st Scientific Meeting of the American Society of Nuclear Cardiology 33
6.5 May 24, 2016: PET imaging with special tracer can detect and diagnose early Alzheimer’s disease 34
6.6 May 18, 2016: Itel Telecomunicazioni Enters into Agreement with Advanced Accelerator Applications 34
6.7 Apr 29, 2016: Advanced Accelerator Applications reports 26.8% sales growth in 2015 and continues to show significant clinical progress across both therapeutic and diagnostic platforms 34
6.8 Apr 21, 2016: CERN Orders LFS Crystals 35
6.9 Apr 11, 2016: PET scans guiding chemo boosts remission for Hodgkin patients 35
6.10 Apr 06, 2016: First Patent Received for New LFS Crystal Formulation 36
6.11 Apr 01, 2016: Zecotek Announces Significant Opportunity for LFS Scintillation Crystals and Enters Radiation Safety and Homeland Security Market Due to World Events and Demand by OEMs 37
6.12 Mar 23, 2016: FluoroPharma Medical Raises USD0.15 Million in Private Placement of Notes 37
6.13 Mar 23, 2016: Chinese OEM Adopts Zecotek’s LFS Scintillation Crystal for New Line of Positron Emission Tomography Medical Scanning Devices 38
6.14 Jan 26, 2016: Zevacor to Produce SomaKit-TATE Doses for AAA 39
6.15 Dec 29, 2015: FluoroPharma Names Dr. Thomas Tulip, PhD Chief Executive Officer 39
6.16 Dec 14, 2015: CapVest Partners Acquires IBA Molecular from Ion Beam Applications and SK Capital Partners for USD69.6 Million 40
6.17 Dec 10, 2015: Advanced Accelerator Applications Reports 37% Growth in Sales for the Third Quarter of 2015 and 32% Growth in Sales for the First Nine Months of 2015 40
6.18 Dec 10, 2015: Zecotek Enters New Market for LFS Crystals 42
6.19 Nov 30, 2015: IBA Molecular North America to become Zevacor Pharma 43
6.20 Nov 05, 2015: Zecotek Receives $250,000 LFS Scintillation Crystal Order 44
6.21 Oct 23, 2015: Nanyang Technological University Enters into Research Agreement with Austrian Institute of Technology and Medical University of Vienna 44
6.22 Sep 17, 2015: University of California Successfully Tests Zecotek’s LFS Scintillation Crystals for High Resolution Positron Emission Tomography Scanning 44
6.23 Jul 28, 2015: JMC Investment Acquires Majority Stake in Keosys 45
6.24 Jun 15, 2015: Advanced Accelerator Applications reports over 24% growth in sales for the first quarter of 2015 45
7 Appendix 47
7.1 Methodology 47
7.2 About GlobalData 49
7.3 Contact Us 50
7.4 Disclaimer 50

1.1 List of Tables
Table 1: Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development 7
Table 2: Positron Emission Tomography (PET) Systems - Pipeline Products by Territory 8
Table 3: Positron Emission Tomography (PET) Systems - Pipeline Products by Regulatory Path 9
Table 4: Positron Emission Tomography (PET) Systems - Pipeline Products by Estimated Approval Date 10
Table 5: Positron Emission Tomography (PET) Systems - Ongoing Clinical Trials 11
Table 6: Positron Emission Tomography (PET) Systems Companies - Pipeline Products by Stage of Development 12
Table 7: Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development 13
Table 8: Brain Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 14
Table 9: CerePET - Product Status 14
Table 10: CerePET - Product Description 14
Table 11: GE Healthcare Limited Pipeline Products & Ongoing Clinical Trials Overview 15
Table 12: Q.Clear - Product Status 15
Table 13: Q.Clear - Product Description 15
Table 14: Jagiellonian University Pipeline Products & Ongoing Clinical Trials Overview 16
Table 15: Positron Emission Tomography System - Product Status 16
Table 16: Positron Emission Tomography System - Product Description 16
Table 17: Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview 17
Table 18: Additional PET Scan - Product Status 17
Table 19: Additional PET Scan - Product Description 18
Table 20: Philips Healthcare - Ongoing Clinical Trials Overview 19
Table 21: Additional PET Scan - Pilot Study Intended to Provide Input for Future Designs Using the PET Alpha Ring Detector and to Support the Pre-market Notification of a Future Product 20
Table 22: Ray Vision Intl Corp. Pipeline Products & Ongoing Clinical Trials Overview 21
Table 23: Helmet - PET System - Product Status 21
Table 24: Helmet - PET System - Product Description 21
Table 25: Stanford University Pipeline Products & Ongoing Clinical Trials Overview 22
Table 26: Breast-Dedicated PET System - Product Status 22
Table 27: Breast-Dedicated PET System - Product Description 23
Table 28: Dual Panel PET Scanner - Product Status 23
Table 29: Dual Panel PET Scanner - Product Description 23
Table 30: Dual-isotope Positron Emitting Tomography System - Product Status 24
Table 31: Dual-isotope Positron Emitting Tomography System - Product Description 24
Table 32: Improved PET System - Product Status 24
Table 33: Improved PET System - Product Description 25
Table 34: MR Compatible PET System - Product Status 25
Table 35: MR Compatible PET System - Product Description 25
Table 36: PET Sensitivity Enhancing Device - Product Status 26
Table 37: PET Sensitivity Enhancing Device - Product Description 26
Table 38: SynchroPET Pipeline Products & Ongoing Clinical Trials Overview 27
Table 39: Breast PET-MRI - Product Status 27
Table 40: Breast PET-MRI - Product Description 27
Table 41: Wrist Scanner - Product Status 28
Table 42: Wrist Scanner - Product Description 28
Table 43: The University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview 29
Table 44: PET Imaging Tool - Product Status 29
Table 45: PET Imaging Tool - Product Description 29
Table 46: Zecotek Photonics Inc. Pipeline Products & Ongoing Clinical Trials Overview 30
Table 47: New Generation PET Scanning Device - Product Status 30
Table 48: New Generation PET Scanning Device - Product Description 31
Table 49: Glossary 48

1.2 List of Figures
Figure 1: Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development 7
Figure 2: Positron Emission Tomography (PET) Systems - Pipeline Products by Territory 8
Figure 3: Positron Emission Tomography (PET) Systems - Pipeline Products by Regulatory Path 9
Figure 4: Positron Emission Tomography (PET) Systems - Pipeline Products by Estimated Approval Date 10
Figure 5: Positron Emission Tomography (PET) Systems - Ongoing Clinical Trials 11

【掲載企業】

Brain Biosciences Inc
GE Healthcare Limited
Jagiellonian University
Philips Healthcare
Ray Vision Intl Corp.
Stanford University
SynchroPET
The University of British Columbia
Zecotek Photonics Inc.

★調査レポート[世界の陽電子放射形コンピューター断層撮影法(PET)装置市場:医療機器パイプライン分析2016]販売に関する免責事項
★調査レポート[世界の陽電子放射形コンピューター断層撮影法(PET)装置市場:医療機器パイプライン分析2016]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆